Status:
RECRUITING
Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Collaborating Sponsors:
Belgium Health Care Knowledge Centre
Conditions:
Glioblastoma
Radiotherapy Side Effect
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the BELGICA trial is to evaluate if radiotherapy could be given in a more focused manner in patients with glioblastoma in order to reduce side effects and improve quality of life. Th...
Eligibility Criteria
Inclusion Criteria:
- Participants capable of giving informed consent
- Age >= 18 y.o.
- WHO performance status 0-2
- Newly diagnosed glioblastoma (Histologically proven glioblastoma per WHO 2021 classification based on biopsy or resection )
- Indication of chemoradiotherapy confirmed by multidisciplinary tumour board
Exclusion Criteria:
- Participation in a competing trial
- Known contraindication to undergo MRI scans
Key Trial Info
Start Date :
May 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2031
Estimated Enrollment :
347 Patients enrolled
Trial Details
Trial ID
NCT06719440
Start Date
May 12 2025
End Date
October 1 2031
Last Update
February 27 2026
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Olv Azorg
Aalst, Belgium, 9300
2
EpiCURA
Baudour, Belgium, 7331
3
AZ Sint Jan
Bruges, Belgium, 8000
4
Institut Jules Bordet
Brussels, Belgium, 1070